HEALTHSTAT NEWS
Expect a clash at today’s FDA peptide panel
The FDA's peptide panel is expected to have a clash today. The panel will discuss peptides over two days, as noted in STAT's Morning Rounds newsletter.
Related Signal
Adjacent reporting
- STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.